Chemoinformaics analysis of BUTYL DODECYL SULFITE
| Molecular Weight | 306.512 | nRot | 16 |
| Heavy Atom Molecular Weight | 272.24 | nRig | 6 |
| Exact Molecular Weight | 306.223 | nRing | 0 |
| Solubility: LogS | -1.699 | nHRing | 0 |
| Solubility: LogP | 2.206 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 54.697 |
| nHD | 0 | BPOL | 42.139 |
| QED | 0.686 |
| Synth | 4.389 |
| Natural Product Likeliness | 1.631 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.927 |
| HIA | 0.327 |
| CACO-2 | -4.803 |
| MDCK | 0.000315697 |
| BBB | 0.481 |
| PPB | 0.280532 |
| VDSS | 1.925 |
| FU | 0.630789 |
| CYP1A2-inh | 0.034 |
| CYP1A2-sub | 0.449 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.924 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.146 |
| CYP2d6-inh | 0.082 |
| CYP2d6-sub | 0.85 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.823 |
| CL | 14.79 |
| T12 | 0.708 |
| hERG | 0.042 |
| Ames | 0.011 |
| ROA | 0.085 |
| SkinSen | 0.451 |
| Carcinogencity | 0.068 |
| EI | 0.012 |
| Respiratory | 0.882 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.707893 |